Fig 1.
Escalation to corticosteroid-sparing therapy for Veterans who were continuous corticosteroid users (CS).
Fig 2.
Escalation to corticosteroid-sparing therapy for Veterans who were intermittent corticosteroid users (IS).
Table 1.
Patient Characteristics of no corticosteroid and all corticosteroid users among IBD Veterans.
Table 2.
Corticosteroid user characteristics among Veterans with and without corticosteroids for IBD only.
Table 3.
Appropriate escalation to corticosteroid-sparing therapy vs. GI visit during the during corticosteroid evaluation period.
Fig 3.
Mean predicted likelihood of escalation to corticosteroid-sparing therapy by deciles of Total Steroid Days among Veterans with a GI visit (square) vs. no GI visit (diamond) during the study period.
Vertical lines (slightly offset for better visibility) represent 95% Confidence Intervals. Predicted escalation adjusted for age, male gender, the use of CS vs. IS, and clustering by facility.
Fig 4.
Risk of Venothromboembolism among Veterans with IBD.
Fig 5.
Risk of Fragility fractures among Veterans with IBD.
Fig 6.
Risk of Infections among Veterans with IBD.
Table 4.
DEXA use among patients using corticosteroids (N = 9,881).